NNIT executive selected for PharmaVOICE 100
Brooke Casselberry recognized as one of industry’s most inspiring
Brooke Casselberry recognized as one of industry’s most inspiring
NNIT and SL Controls have agreed to join forces. SL Controls will further strengthen NNIT’s solutions within Production IT and is yet another step towards consolidating the NNIT Group as one of the foremost suppliers of IT services to the global life sciences industry.
Pär Fors was on sabbatical, contemplating his next executive challenge when he was approached by NNIT’s Board of Directors. As talks progressed, it became clear that NNIT fit the bill: a CEO role within the tech industry, in a company with a clear and ambitious strategy for international expansion, but slightly different to other players due to its focus on life science.
Today, NNIT’s Board of Directors have entered into an agreement with Pär Fors who will join NNIT as CEO as of June 14, 2021. Pär Fors will replace Per Kogut who has served as NNIT’s CEO since 2007.
At NNIT, we have identified four SDGs as the focus of our corporate responsibility work; one of them is SDG #5 aiming to achieve gender equality and empower all women and girls.
In Q1, we experienced continued strong growth within the International Life Sciences business, with Excellis performing to plan. Our Private & Public business started to see positive momentum in relation to the Winning Solutions strategy, which now constitutes 49% of NNIT’s revenue.
NNIT supports the Danish initiative Coding Class as part of its commitment to the UN SDG 4 about Quality Education. Through Coding Class, children learn how to navigate in a digital world. This week, NNIT’s first coding class of 2021 ended with a coding finale.
Every year, NNIT conducts an Expectation Barometer survey among larger companies centered on a theme. This year’s theme is “Digital Resilience,” and the first results, based on answers from more than 400 respondents, are in.
In 2021 alone, NNIT A/S has hired 200 new employees, and manning up will continue well into the year to support future business growth, mainly within NNIT’s strategic focus areas. Currently, we are looking to fill 250 vacancies – within virtually all areas and at all levels.
Across the life sciences industry, pharma companies are seeking new ways to respond to the high agility required to produce complex products like personalized cancer treatment, cell and gene therapy and Covid-19 vaccines. Central to these efforts is the manufacturing execution system (MES), which allows pharma companies to adopt pharma 4.0 production and manage their data flows to expedite product
Hos NNIT ansætter vi en række studerende og praktikanter, som er engagerede i digital udvikling, og som ønsker en vigtig rolle i at realisere vores kunders IT-potentiale. Rasmus Roug Nyeland er en af dem, læs her hvad han har at sige om sit studiejob.
I januar udgav vi vores Corporate Responsibility-rapport om de mål, vi har nået i 2020. Vigtigst af alt skitserer rapporten, hvordan vi vil øge vores fokus på ansvarlighed for vores omgivelser.